Intuitive Surg. (ISRG) ebitda was $4.3B in FY2025 (+25% YoY). The tables below show the complete quarterly and annual ebitda history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual EBITDA
Fiscal Year
EBITDA
YoY
2025
$4.3B
+25%
2024
$3.5B
+27%
2023
$2.7B
+14%
2022
$2.4B
-5%
2021
$2.6B
+53%
2020
$1.7B
-11%
2019
$1.9B
+19%
2018
$1.6B
+16%
2017
$1.4B
+13%
2016
$1.2B
+24%
2015
$969M
+27%
2014
$766M
-28%
2013
$1.1B
+0%
2012
$1.1B
+24%
2011
$860M
+23%
2010
$696M
+41%
2009
$493M
+23%
2008
$402M
+58%
2007
$254M
Recent Quarterly EBITDA
Quarter
EBITDA
Q2 2026
$1.2B
Q1 2026
$1.1B
Q4 2025
$1.7B
Q3 2025
$969M
Q2 2025
$946M
Q1 2025
$771M
Q4 2024
$1.3B
Q3 2024
$757M
Q2 2024
$749M
Q1 2024
$630M
Q4 2023
$969M
Q3 2023
$628M
Source: ISRG on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.